PULMOTUS

This brand name is authorized in Turkey.

Active ingredients

The drug PULMOTUS contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3O31P6T4G3 - LEVODROPROPIZINE
 

Levodropropizine is a drug provided with a mainly peripheral tracheobronchial antitussive effect together with an antiallergic and antibronchospastic effect.
 
Read more about Levodropropizine
2
UNII V1Q0O9OJ9Z - CHLORPHENIRAMINE MALEATE
 

Chlorphenamine is a potent antihistamine (H1-antagonist). Antihistamines diminish or abolish the actions of histamine in the body by competitive reversible blockade of histamine H1-receptor sites on tissues. Chlorphenamine also has anticholinergic activity.
 
Read more about Chlorphenamine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05DB20 Combinations R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DB Other cough suppressants
Discover more medicines within R05DB20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
TR İlaç ve Tıbbi Cihaz Kurumu 8680150570121

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈